Cancer clinical trials in the region Grand Est

288 currently recruiting clinical trials
Region Grand Est
Phase 2 Liver and bile duct cancer #NCT06529718 #2024-515875-36-00
Required histologic sub types
Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
1
Required previous treatments at advanced or metastatic stage
Chemotherapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
20 recruiting sites
UNICANCER
Phase 2 Stomach and esophageal cancer #NCT06253611 #2023-506753-38-00
Required histologic types
Stomach Oesogastric junction Esophagus
Required histologic sub types
Adenocarcinoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded genetic anomalies
HER2
Excluded previous treatments at advanced or metastatic stage
Immunotherapy
15 recruiting sites
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2 Lymphoma #NCT06588478 #2024-515689-15-01
Required histologic types
B cell lymphoma
Required histologic sub types
Lymphocytic lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
6 recruiting sites
Loxo Oncology
Phase 2 CLL & Richter's syndrome #NCT06588478 #2024-515689-15-01
Required histologic types
CLL (Chronic Lymphocytic Leukemia)
Required number of previous lines of therapy
1 2 3 or more
Required previous treatments
Targeted therapy
Excluded previous treatments
Systemic Treatment-Naive
6 recruiting sites
Loxo Oncology
Phase 2 Lymphoma #NCT06588478 #2024-515689-15-01
Required histologic types
B cell lymphoma
Required histologic sub types
Lymphocytic lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
1 2 3 or more
Required previous treatments
Targeted therapy
Excluded previous treatments
Systemic Treatment-Naive
6 recruiting sites
Loxo Oncology
Phase 2 CLL & Richter's syndrome #NCT06588478 #2024-515689-15-01
Required histologic types
CLL (Chronic Lymphocytic Leukemia)
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
6 recruiting sites
Loxo Oncology
Phase 2 Colon cancer Rectal cancer #NCT06425133 #2023-509761-21-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Required previous treatments at advanced or metastatic stage
Immunotherapy Chemotherapy Targeted therapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
9 recruiting sites
Centre Hospitalier Universitaire de Besancon
Phase 2 Kidney cancer #NCT05865730 #2024-516711-24-00
Required histologic types
Clear cell carcinoma
Required disease stage
Locally Advanced Metastatic
2 recruiting sites
EverImmune
Phase 2 Lung cancer #NCT05865730 #2024-516711-24-00
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required histologic sub types
Non-squamous NSCLC
Required disease stage
Metastatic
Required PDL1 statuses
PDL1 Positive (>= 50%)
2 recruiting sites
EverImmune
Phase 2 Liver and bile duct cancer #NCT05528952
Required histologic sub types
Hepatocellular carcinoma
Required disease stage
Locally Advanced Metastatic
Required liver status
Unhealthy
Required Child-Pugh scores
A
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at advanced or metastatic stage
Immunotherapy
11 recruiting sites
CHU de Besançon